From clinic to practice in NSCLC patients with exon 20 mutations

From clinic to practice in NSCLC patients with exon 20 mutations

Available Clinical Research in the Care of Patients with NSCLC with an EGFR MutationПодробнее

Available Clinical Research in the Care of Patients with NSCLC with an EGFR Mutation

ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431Подробнее

ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLCПодробнее

A Visual Exploration of New Targeted Therapies for EGFR Exon 20 Insertions in NSCLC

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient Forum

Targeted treatments for EGFR exon 20 insertion mutations in NSCLCПодробнее

Targeted treatments for EGFR exon 20 insertion mutations in NSCLC

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLCПодробнее

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

The evolving treatment landscape for NSCLC with EGFR exon 20 insertion mutationsПодробнее

The evolving treatment landscape for NSCLC with EGFR exon 20 insertion mutations

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicityПодробнее

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicity

Live Well Breathe Better - Lung Cancer: Targeted Therapy for lung cancer treatmentПодробнее

Live Well Breathe Better - Lung Cancer: Targeted Therapy for lung cancer treatment

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 InsertionПодробнее

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

События